Teva Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TEVA PHARMS INC, and what generic and branded alternatives to TEVA PHARMS INC drugs are available?
TEVA PHARMS INC has six approved drugs.
There are two tentative approvals on TEVA PHARMS INC drugs.
Drugs and US Patents for Teva Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms Inc | PAZOPANIB HYDROCHLORIDE | pazopanib hydrochloride | TABLET;ORAL | 217517-001 | Oct 19, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Pharms Inc | ALVAIZ | eltrombopag choline | TABLET;ORAL | 216774-004 | Nov 29, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Teva Pharms Inc | ALYQ | tadalafil | TABLET;ORAL | 216932-001 | Oct 12, 2022 | AB2 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Pharms Inc | PACLITAXEL | paclitaxel | POWDER;INTRAVENOUS | 216338-001 | May 11, 2023 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva Pharms Inc | ALVAIZ | eltrombopag choline | TABLET;ORAL | 216774-001 | Nov 29, 2023 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.